Imagen de Portada

Challenges and advances of immune checkpoint therapy

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Lingyu Li, Yingli Sun
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Clinical and Translational Discovery
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Tumour hepcidin levels as a biomarker for predicting response to immune checkpoint inhibition in advanced non‐small cell lung cancer
por: Yuichiro Suzukawa, et al.
Publicado: (2026)

scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
por: Fansen Ji, et al.
Publicado: (2025)

A comprehensive atlas of pediatric immune checkpoint inhibitors‐related adverse events: From real‐world pharmacovigilance data to mechanistic insights
por: Anqi Lin, et al.
Publicado: (2025)

Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
por: Xinni Chen, et al.
Publicado: (2026)

Impacts of immune microenvironment on musculoskeletal health
por: Ren Xu
Publicado: (2024)

Host immune collapse in influenza‐associated pulmonary aspergillosis: From barrier dysfunction to metabolic paralysis
por: Liangyu Li, et al.
Publicado: (2026)

EccDNA, STING activation, and their potential roles in DLBCL prognosis and therapy
por: Xi‐Bo Hu, et al.
Publicado: (2024)

Sex differences in structural cell‐mediated immune regulation: Implications for precision respiratory medicine
por: Quocdai Vu, et al.
Publicado: (2026)

Sex differences in genomics, immune microenvironment and immunotherapy response in adult grade 4 gliomas
por: Feng Tang, et al.
Publicado: (2026)

GWAS advancements to investigate disease associations and biological mechanisms
por: Oluwaferanmi Omidiran, et al.
Publicado: (2024)

Targeting CD70 in cancer: Mechanisms of immune escape and translational opportunities
por: Akash Sabarwal, et al.
Publicado: (2025)

Targeting mutated KRAS in the first‐line therapy
por: Hideaki Ijichi
Publicado: (2024)

CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
por: Dongchun Xie, et al.
Publicado: (2024)

Current advances in the role of classical non‐homologous end joining in hematologic malignancies
por: Pengcheng Liu, et al.
Publicado: (2025)

Tertiary lymphoid structures: Defining immune subtypes and enabling precision immunotherapy in nasopharyngeal carcinoma
por: Fan Liu, et al.
Publicado: (2025)

Milk exosomes: Harnessing nature's duality for cancer therapy
por: Asmit Das, et al.
Publicado: (2024)

Engineered cell versus modified exosomes in cancer therapy
por: Rajib Dhar, et al.
Publicado: (2024)

Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies
por: Yushan Huang, et al.
Publicado: (2026)

Platelet volume could predict the efficacy of thrombopoietin receptor agonists in the treatment of patients with primary immune thrombocytopenia
por: Bei Xu, et al.
Publicado: (2025)

Effects of microRNA on the growth and targeted therapy response on lung cancer
por: Mengchen Zhu, et al.
Publicado: (2024)

Liquid biopsy—A biomarker‐based revolutionising technique in cancer therapy
por: Subham Sarkar, et al.
Publicado: (2024)

Mesenchymal stem cell therapy for ulcerative colitis: Opportunities and challenges in precision medicine
por: Peng‐Fei Wang, et al.
Publicado: (2025)

Bacterial surface derived extracellular vesicles: A ground‐breaking approach in cancer therapy
por: Asmit Das, et al.
Publicado: (2024)

Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
por: Swastika Maitra, et al.
Publicado: (2024)

Sculpting nursing resilience: Transforming lives, nurturing ethics in chimeric antigen receptor T‐cell therapy
por: Pranay Bende
Publicado: (2024)

The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy
por: Jing Zhao, et al.
Publicado: (2025)

From channel‐spatial attention to state space models: A review of evolving mechanisms in tumour segmentation
por: Yanfei Sun, et al.
Publicado: (2026)

Precision treatment paradigm: Genomic features and therapeutic implications in mesenchymal‐epithelial transition‐amplified gastric cancer
por: Yiyi Yu, et al.
Publicado: (2024)

High expression of miR5700 in atypical type A thymoma and its role in promoting tumour progression
por: Li Zhao, et al.
Publicado: (2026)

Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatment
por: Xiaolu Zhang, et al.
Publicado: (2024)

Single‐cell sequencing for cancer precision medicine: From mechanism discovery to diagnosis and therapeutics
por: Yue Zhao, et al.
Publicado: (2026)

Gut microbiota and central nervous system's direct bidirectional regulation: The mechanisms of the gut–brain axis in irritable bowel syndrome
por: Jinxia Zhai, et al.
Publicado: (2026)

Translation products of circular RNAs and their functions and application prospects in colorectal cancer
por: Fengsen Wang, et al.
Publicado: (2026)

Epigenetic dynamics in gastric cancer precancerous lesions: From molecular mechanisms to precision risk stratification
por: Kewei Ma, et al.
Publicado: (2025)

The role of T cells in sepsis of distinct infectious aetiologies
por: Xuanqi Liu, et al.
Publicado: (2026)

Significance of stereologically spatiotemporal cells in molecular medicine
por: Xuanqi Liu, et al.
Publicado: (2025)

Mechanisms, impacts and therapeutic strategies of glucose metabolic reprogramming in tumours
por: Li Ma, et al.
Publicado: (2025)

Epigenetic regulation of Epstein–Barr virus: From bench to bedside
por: Xiao Gao, et al.
Publicado: (2024)

Safety and efficacy of isocitrate dehydrogenase‐1 inhibitor ivosidenib in patients with cholangiocarcinoma
por: Lindsay Wong, et al.
Publicado: (2026)

CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin
por: Shi‐Jia Dai, et al.
Publicado: (2026)